ATE131828T1 - Peptide mit schutzeigenschaften gegen ein pathogenes virus des hiv-typs in sensitiven zellen - Google Patents

Peptide mit schutzeigenschaften gegen ein pathogenes virus des hiv-typs in sensitiven zellen

Info

Publication number: ATE131828T1
Authority: AT; Austria
Prior art keywords: peptides; properties against; protective properties; sensitive cells; pathogenic virus
Prior art date: 1988-06-06

Application number

AT89907183T

Other languages

English (en)

Inventor

Jean-Michel Claverie

Lydie Bougeleret

Philippe Kourilsky

Pierre Langlade-Demoyen

Ada Chalufour-Prochnicka

Gilles Dadaglio

Fredj Tekaia

Fernando Plata

Original Assignee

Pasteur Institut

Inst Nat Sante Rech Med

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-06-06

Filing date

1989-06-06

Publication date

1996-01-15

1989-06-06 Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut

1996-01-15 Application granted granted Critical

1996-01-15 Publication of ATE131828T1 publication Critical patent/ATE131828T1/de

Links

102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
241000700605 Viruses Species 0.000 title 1
230000001717 pathogenic effect Effects 0.000 title 1
230000001681 protective effect Effects 0.000 title 1
LMYRMZCIVJDSCP-OWYYFYIDSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-2-[(2-aminoacetyl)amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-5-oxopentanoyl]amino]propanoyl]amino]propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-car Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 LMYRMZCIVJDSCP-OWYYFYIDSA-N 0.000 abstract 1
QXMRVPVPQQYLDJ-NWENKFQXSA-N (4s)-4-[[(2s)-1-[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-4-amino-2-[(2-aminoacetyl)amino]-4-oxobutanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CN)C1=CC=CC=C1 QXMRVPVPQQYLDJ-NWENKFQXSA-N 0.000 abstract 1
OIAMNEBINSJKBD-UAJVRZNWSA-N (4s)-4-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[2-[[(2s)-1-[(2s)-2-[[(2s,3s)-2-[[(2s)-1-[2-[[(2s)-2-[[(2s)-2-amino-3-(1h-imidazol-5-yl)propanoyl]amino]propanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoyl]amino]propanoyl]pyrrolidine-2-carbony Chemical compound C([C@H](N)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(O)=O)C1=CN=CN1 OIAMNEBINSJKBD-UAJVRZNWSA-N 0.000 abstract 1
JZCNZKYQBJKBMM-MTNZBRKKSA-N 119400-72-5 Chemical compound C([C@@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCCCN)C1=CN=CN1 JZCNZKYQBJKBMM-MTNZBRKKSA-N 0.000 abstract 1
102220531773 Calcium channel flower homolog_H15G_mutation Human genes 0.000 abstract 1
241000725303 Human immunodeficiency virus Species 0.000 abstract 1
230000002101 lytic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT89907183T 1988-06-06 1989-06-06 Peptide mit schutzeigenschaften gegen ein pathogenes virus des hiv-typs in sensitiven zellen ATE131828T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR8807504A FR2632310B1 (fr)	1988-06-06	1988-06-06	Peptides ayant des proprietes protectrices d'un virus pathogene du type hiv dans des cellules sensibles

Publications (1)

Publication Number	Publication Date
ATE131828T1 true ATE131828T1 (de)	1996-01-15

Family

ID=9366976

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT89907183T ATE131828T1 (de)	1988-06-06	1989-06-06	Peptide mit schutzeigenschaften gegen ein pathogenes virus des hiv-typs in sensitiven zellen

Country Status (5)

Country	Link
EP (1)	EP0375767B1 (de)
AT (1)	ATE131828T1 (de)
DE (1)	DE68925191D1 (de)
FR (1)	FR2632310B1 (de)
WO (1)	WO1989012066A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2677654B1 (fr) *	1991-06-17	1995-11-17	Pasteur Merieux Serums Vacc	Composes a effet immunogene anti-cytokine, a effet immunogene anticytostatique ou a effet vaccinal anti-infection a hiv.
GB2290293A (en) *	1994-06-08	1995-12-20	Rupert Donald Holms	Preparation which inhibits the autoimmune response in HIV, or SLE, patients

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8501473D0 (en) *	1985-01-21	1985-02-20	Pasteur Institut	Cloned dna sequences
EP0387915B1 (de) *	1984-10-18	1993-03-10	Institut Pasteur	F Antigene vom menschlichen Immunodefizienz-Virus und deren Verwendungen
AU6713287A (en) *	1986-01-06	1987-07-09	F. Hoffmann-La Roche & Co.	Expression of htlv-iii gag-gene
US5075211A (en) *	1986-03-26	1991-12-24	Genetic Systems Corporation	Synthetic antigen for the detection of AIDS-related disease
US4925784A (en) *	1986-04-04	1990-05-15	Hoffmann-La Roche Inc.	Expression and purification of an HTLV-III gag/env gene protein
FR2600335B1 (fr) *	1986-06-19	1988-09-30	Pasteur Institut	Procede d'analyse des sequences peptidiques immunogenes portant un epitope caracteristique d'une proteine etrangere a l'organisme d'un hote vivant, en vue de la production de vaccins
NZ221440A (en) *	1986-08-20	1991-11-26	Genetic Systems Corp	Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections

1988
- 1988-06-06 FR FR8807504A patent/FR2632310B1/fr not_active Expired - Lifetime
1989
- 1989-06-06 WO PCT/FR1989/000285 patent/WO1989012066A1/fr not_active Ceased
- 1989-06-06 EP EP89907183A patent/EP0375767B1/de not_active Expired - Lifetime
- 1989-06-06 DE DE68925191T patent/DE68925191D1/de not_active Expired - Lifetime
- 1989-06-06 AT AT89907183T patent/ATE131828T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE68925191D1 (de)	1996-02-01
FR2632310A1 (fr)	1989-12-08
EP0375767B1 (de)	1995-12-20
FR2632310B1 (fr)	1992-04-10
EP0375767A1 (de)	1990-07-04
WO1989012066A1 (fr)	1989-12-14

Similar Documents

Publication	Publication Date	Title
DE69632256D1 (de)	2004-05-27	Antivirale proteine, dafür kodierende dna, und deren verwendung
ES2194029T3 (es)	2003-11-16	Variantes del virus hiv-2.
ATE520783T1 (de)	2011-09-15	Lentivirale vektoren
EA199901031A1 (ru)	2000-06-26	Производные бензимидазола
ES2078255T3 (es)	1995-12-16	Regiones inmunogenas en la proteina e-7 del papilomavirus humano tipo 16.
EP0269712A4 (de)	1990-06-26	An der pathogenese einer hiv-infektion beteiligte peptide.
ES2182837T3 (es)	2003-03-16	Piran-2-onas y 5,6-dihidropiran-2-onas utiles en el tratamiento del sida y de otros retrovirus.
CL2009002139A1 (es)	2010-05-07	Peptido sintetico que comprende la secuencia sec id no:6 y sec id no:7 de la proteina gp41 del virus vih con actividad antiretroviral.
RU95108217A (ru)	1997-06-10	Дефектный рекомбинантный аденовирус, линия клеток, фармацевтическая композиция
CA2164818A1 (en)	1994-12-22	Tandem synthetic hiv-1 peptides
ES2061500T3 (es)	1994-12-16	Diagnosis y vacunas de la hepatitis delta su preparacion y uso.
CY1109439T1 (el)	2014-08-13	Αναλογα γλυκοπρωτεϊνικων ορμονων δισουλφιδικης σταυρωτης συνδεσης, η παρασκευη και η χρηση τους
ES2045475T3 (es)	1994-01-16	Rna del genoma del virus de la hepatitis no-a, no-b, cdna y proteina del antigeno del virus.
ATE54009T1 (de)	1990-07-15	Molekulare klone des genoms von htlv-iii.
ATE174222T1 (de)	1998-12-15	Blockierung der anlagerung von keimen an menschliche zellen
RU94041224A (ru)	1995-09-10	Пептиды с органозащитной активностью, фармацевтическая композиция на их основе и их применение в терапии
DK1169057T3 (da)	2005-03-07	Anti-HIV-1-vaccine, der omfatter det hele eller en del af HIV-1-Tat-proteinet
DE68910577D1 (de)	1993-12-16	Mittel gegen den AIDS-Virus.
ES2061495T3 (es)	1994-12-16	Peptidos relacionados con el virus htlv-iii, anticuerpos para los peptidos, vacunas, inmunizacion activa y pasiva contra el virus del sida y prueba diagnostica para la deteccion serologica del virus del sida.
DE69534361D1 (de)	2005-09-08	Therapeutische Quassinoid-Zubereitungen mit antineoplastischer, antiviraler und herbistatischer Wirkung
DE68925191D1 (de)	1996-02-01	Peptide mit schutzeigenschaften gegen ein pathogenes virus des hiv-typs in sensitiven zellen
IT1249684B (it)	1995-03-09	Epitopi della proteina env del virus dell'epatite c.
ATE58478T1 (de)	1990-12-15	Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.
DE3886371D1 (de)	1994-01-27	Herstellung des hblv-virus in der hsb-2 zell-linie.
DE68918033D1 (de)	1994-10-13	Schutz zur Abnutzungsverringerung von Fingerhutrohren.

Legal Events

Date	Code	Title	Description
1996-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties